MDA Stock Overview
Develops solutions to support diagnostic imaging and digital medicine in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
MedApp S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.15 |
| 52 Week High | zł0.42 |
| 52 Week Low | zł0.15 |
| Beta | 0.92 |
| 1 Month Change | -12.86% |
| 3 Month Change | -25.61% |
| 1 Year Change | -54.20% |
| 3 Year Change | -83.60% |
| 5 Year Change | -83.95% |
| Change since IPO | 69.44% |
Recent News & Updates
Recent updates
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
Shareholder Returns
| MDA | PL Healthcare Services | PL Market | |
|---|---|---|---|
| 7D | -11.1% | -2.1% | -3.8% |
| 1Y | -54.2% | 12.7% | -5.2% |
Return vs Industry: MDA underperformed the Polish Healthcare Services industry which returned 14.2% over the past year.
Return vs Market: MDA underperformed the Polish Market which returned -2.3% over the past year.
Price Volatility
| MDA volatility | |
|---|---|
| MDA Average Weekly Movement | 7.5% |
| Healthcare Services Industry Average Movement | 5.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.7% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: MDA's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: MDA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 22 | David Odrakiewicz | medapp.pl |
MedApp S.A. develops solutions to support diagnostic imaging and digital medicine in Poland. The company offers CarnaLife System, an analytical telemedicine system that enables physician to assess and monitor the health of patients and conduct consultations, as well as enable remote measurement, such as pulse oximeter, electrocardiograph, blood pressure monitor, thermometer, scale, auscultation device, and others. It also offers CarnaLife Holo, a 3D imaging system for 3D visualization imaged medical data, which supports the planning and performance of medical procedures; Digital Clinic that offers remote medical care, medical consultations, diagnostics, and in-depth health monitoring; and HoloComm for remote product demonstration in 3D.
MedApp S.A. Fundamentals Summary
| MDA fundamental statistics | |
|---|---|
| Market cap | zł38.15m |
| Earnings (TTM) | -zł4.11m |
| Revenue (TTM) | zł5.33m |
7.2x
P/S Ratio-9.3x
P/E RatioIs MDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDA income statement (TTM) | |
|---|---|
| Revenue | zł5.33m |
| Cost of Revenue | zł1.05m |
| Gross Profit | zł4.28m |
| Other Expenses | zł8.39m |
| Earnings | -zł4.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | 80.27% |
| Net Profit Margin | -77.14% |
| Debt/Equity Ratio | 7.4% |
How did MDA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 05:29 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |